By

Sara Dagen

Axogen’s Aim: Growing Tampa Into a Hub for Nerve Repair Treatment Technology

As a biotech company at the forefront of nerve repair treatment, UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, has always been near the front of the scientific curve.

Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines

UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced it has entered into a licensing agreement with the National Research Council of Canada (NRC) that will enable Oragenics to pursue the rapid development of next-generation vaccines against the SARS-CoV-2 virus and its variants.

‘A Year of Change’: UF Reflects on COVID-19 Milestones

The University of Florida is reflecting back on the milestones made in the last year through the COVID-19 pandemic. From the initial lockdown in March 2020 to the rollout of vaccines in December, reflecting back on the year of change helps us see just how far we’ve come.

UF and Scripps Research Announce Talks To Integrate

In a move designed to marry the clinical and educational expertise of the state’s flagship university with one of the world’s premier biomedical research enterprises, the University of Florida and Scripps Research announced they are in talks to integrate the Florida-based branch of Scripps Research with the research arm of UF’s academic health center.